Medicare Enrolled

Dr. Sumana Gangi, M.D

Internal Medicine · Mesquite, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
1621 N. BELTLINE RD, Mesquite, TX 75149
9726825700
In practice since 2006 (19 years)
NPI: 1487679213 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gangi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gangi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gangi

Dr. Sumana Gangi is an internal medicine specialist in Mesquite, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Gangi performed 20,236 Medicare services across 8,716 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gangi received a total of $970,329 from 67 pharmaceutical and/or device companies across 1925 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gangi is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 2% volume in TX $970,329 industry payments

Medicare Practice Summary

Medicare Utilization ↗
20,236
Medicare services
Top 2% in TX for internal medicine
8,716
Unique beneficiaries
$31
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,065 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 4,801 $18 $42
Chronic care management, first 20 min/month 2,105 $31 $42
Office visit, established patient (30-39 min) 2,007 $89 $183
Blood draw (venipuncture) 1,491 $8 $10
Comprehensive metabolic blood panel 1,086 $10 $30
Thyroid stimulating hormone (TSH) test 1,017 $16 $40
Hemoglobin A1c test (diabetes monitoring) 912 $9 $31
Blood glucose (sugar) level 893 $4 $10
Free thyroxine (T4) test 863 $9 $30
Thyroid hormone, t3 measurement, total 713 $14 $30
Lipid panel (cholesterol and triglycerides) 596 $13 $25
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report 539 $25 $130
Office visit, established patient (20-29 min) 356 $65 $150
Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month 326 $71 $93
Vitamin D level test 307 $29 $40
New patient office visit (45-59 min) 273 $118 $250
Testing of autonomic (sympathetic) nervous system function 226 $92 $400
Complete ultrasound study of arm and leg arteries 222 $100 $300
Electrocardiogram (ecg) 1 to 3 leads with review by physician 217 $10 $100
Testing of autonomic (sympathetic and parasympathetic) nervous system function, at least 5 minutes of tilt 214 $118 $400
Ultrasound scan of head and neck soft tissue 200 $81 $400
Complete blood count (CBC) with differential 174 $8 $20
Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month 115 $35 $47
Drug injection, under skin or into muscle 113 $10 $50
Thyroglobulin (thyroid protein) antibody measurement 71 $16 $45
Microsomal antibodies (autoantibody) measurement 65 $14 $40
Vitamin B-12 level test 59 $15 $40
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment 55 $112 $445
Fine needle aspiration biopsy using ultrasound guidance, first growth 41 $105 $300
Office visit, established patient, complex (40-54 min) 35 $134 $250
Basic metabolic blood panel 30 $8 $30
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin 30 $46 $200
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional 28 $18 $50
Testosterone (hormone) level, total 23 $25 $40
New patient office visit, complex (60-74 min) 22 $163 $310
New patient office visit (30-44 min) 11 $88 $180
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$970,329
Total received (2018-2024)
Avg $138,618/year across 7 years
Top 0% in TX for internal medicine
67
Companies
1,925
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$951,888 (98.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,517 (1.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,924 (0.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$42,893
2023
$69,103
2022
$137,619
2021
$97,804
2020
$128,358
2019
$247,757
2018
$246,795

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$416,402
Novo Nordisk Inc
$312,888
SANOFI-AVENTIS U.S. LLC
$69,998
AstraZeneca Pharmaceuticals LP
$57,697
Boehringer Ingelheim Pharmaceuticals, Inc.
$53,889
Merck Sharp & Dohme Corporation
$44,386
Mannkind Corporation
$4,134
Novo Nordisk AS
$2,430
Eli Lilly and Company
$1,969
Amgen Inc.
$647
Abbott Laboratories
$606
Dexcom, Inc.
$404
ABBVIE INC.
$399
Tandem Diabetes Care, Inc.
$314
Radius Health, Inc.
$292
MannKind Corporation
$262
Esperion Therapeutics, Inc.
$244
Amneal Pharmaceuticals LLC
$198
Amarin Pharma Inc.
$190
IBSA Pharma Inc.
$176
PFIZER INC.
$173
AbbVie Inc.
$159
CeQur Corporation
$143
GRT US Holding, Inc.
$141
Zealand Pharma US, Inc.
$133
Becton, Dickinson and Company
$132
Bayer HealthCare Pharmaceuticals Inc.
$129
Medtronic, Inc.
$105
Insulet Corporation
$99
Corcept Therapeutics
$87
Shire North American Group Inc
$84
Amryt Pharma Holdings Ltd
$80
Alexion Pharmaceuticals, Inc.
$78
AbbVie, Inc.
$77
RECORDATI_RARE_DISEASES_INC.
$77
Xeris Pharmaceuticals, Inc.
$72
DEXCOM, INC.
$66
Horizon Therapeutics plc
$63
ARBOR PHARMACEUTICALS, INC.
$58
Novartis Pharmaceuticals Corporation
$49
Intuity Medical Inc
$49
Ultragenyx Pharmaceutical Inc.
$47
Nevro Corp.
$46
Medtronic MiniMed, Inc.
$44
Kowa Pharmaceuticals America, Inc.
$43
Valeritas, Inc.
$41
Companion Medical, Inc.
$38
VistaPharm, Inc.
$36
Regeneron Healthcare Solutions, Inc.
$35
LifeScan, Inc.
$34
Antares Pharma, Inc.
$34
LIFESCAN, INC.
$33
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$32
Endo Pharmaceuticals Inc.
$30
BETA BIONICS, INC.
$29
Acerus Pharmaceuticals Corporation
$28
Verity Pharmaceuticals Inc.
$27
Janssen Pharmaceuticals, Inc
$27
Bayer Healthcare Pharmaceuticals Inc.
$20
Averitas Pharma Inc.
$20
Acella Pharmaceuticals, LLC
$20
Astellas Pharma US Inc
$19
Alfasigma USA, Inc.
$16
Ascensia Diabetes Care US Inc.
$14
Nalpropion Pharmaceuticals, Inc.
$14
Amphastar Pharmaceuticals, Inc.
$13
Merck Sharp & Dohme LLC
$9
Top 3 companies account for 82.4% of total payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · BASAGLAR · BD Nano · BD Nano 2nd Gen Pen Needle · BRILINTA · CHANTIX · CONTRAVE · CYCLOSET · CeQur Simplicity · Corlanor · Crysvita · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom CGM · Dexcom G6 Transmitter · ENTRESTO · EVENITY · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · HUMALOG · HUMULIN · HUMULIN U · Horizant · INTELLIS ADAPTIVESTIM · INVOKANA · InPen · JANUVIA · JARDIANCE · Kerendia · Korlym · LANTUS · LEQVIO · LICART · LINZESS · LYRICA · Levemir · Livalo · MINIMED 780G · MOUNJARO · MYCAPSSA · Minimed 670G System · NASCOBAL · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NP Thyroid 60 · Natesto · ONETOUCH VERIO FLEX · OT Verio Reflect "One Touch Meter and Strips" · OTREXUP · Omnia · Omnipod · OneTouch · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PROCLAIM · Pogo Automatic Blood Glucose Monitoring System · Prolia · QUTENZA · Qutenza · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOLIRIS · SOMAVERT · STEGLATRO · STEGLUJAN · SYNTHROID · Saxenda · Senza · Strensiq · Synthroid · TEPEZZA · TOUJEO · TRULICITY · TZIELD · Thyquidity · Tirosint · Tlando · Tresiba · Tymlos · UBRELVY · UNITHROID · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · Vascepa · Veozah · Victoza · Wegovy · XIAFLEX · XYOSTED · Xultophy 100/3.6 · ZEGALOGUE · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (98%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in internal medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for internal medicine in TX.

Equivalent to $4,795 per 100 Medicare services performed
Looking for an internal medicine specialist in Mesquite?
Compare internal medicine physicians in the Mesquite area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
1,803
Per 100K population
69.2
County median income
$74,149
Nearest hospital
DALLAS REGIONAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Gangi is a clinical cardiology specialist, with above-average Medicare volume (top 2% in TX), with speaking/promotional industry engagement in the top 0% of TX peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Gangi experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Gangi performed 4,801 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gangi receive payments from pharmaceutical companies?
Yes. Dr. Gangi received a total of $970,329 from 67 companies across 1,925 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gangi's costs compare to other internal medicine physicians in Mesquite?
Dr. Gangi's average Medicare payment per service is $31. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gangi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →